Recursion Pharmaceuticals Inc Clas (RXRX)
Financing Cash Flow
$378.61M
TTM · Period ending: · USD
RXRX Financing Cash Flow
Latest reported$378.61Mperiod ending
Latest reported$378.61Mperiod ending
RXRX TTM Cash from Financing ($246.14M → $378.61M)
TTM financing cash flow
High-resolution chart · PNG
RXRX financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 378,609,000 | |
| 477,535,000 | |
| 521,532,000 | |
| 400,165,000 | |
| 165,287,000 | |
| 330,750,000 | |
| 304,120,000 | |
| 374,140,000 | |
| 411,443,000 | |
| 152,108,000 | |
| 140,133,000 | |
| 206,730,000 | |
| 155,302,000 | |
| 154,183,000 | |
| 154,345,000 | |
| 10,885,000 | |
| -2,547,000 | |
| 458,490,000 | |
| 458,540,000 | |
| 464,779,000 | |
| 705,595,000 | |
| 242,272,000 | |
| 246,135,000 |